Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 3

Sponsor Class

OTHER 7INDUSTRY 3

Study Type

Interventional 2Observational 1

Sponsor

Conditions

Leiomyoma 3Myoma 2Menorrhagia 2Myofibroma 1

Interventions

telapristone acetate 18vilaprisan 12relugolix 11estradiol, norethindrone drug combination 9asoprisnil 9Estradiol 8elagolix 7Uterine Myomectomy 7ulipristal acetate 6Norethindrone Acetate 6Leuprolide 5linzagolix 4Uterine Artery Embolization 3Sugars 3ulipristal 2Progestins 2Mifepristone 2epigallocatechin gallate 1carbetocin 1Vitamin D 1Vitamin B 6 1Therapeutics 1Standard of Care 1Sodium Chloride 1Robotic Surgical Procedures 1Radiofrequency Ablation 1Progesterone 1Microbial Collagenase 1Megestrol Acetate 1Medroxyprogesterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Leiomyoma × Uterine Artery Embolization × Clear all
NCT02163525 2025-09-30

Post Market TRUST - U.S.A. Study

Acessa Health, Inc.

Phase NA Completed
114 enrolled

Leiomyoma, Menorrhagia, Myoma

NCT01563783 2023-02-01

TRUST

Acessa Health, Inc.

Phase NA Completed
84 enrolled

Leiomyoma, Menorrhagia, Myoma

NCT02819609 2016-06-30

Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids

Quintiles, Inc.

Completed
12,234 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡